IL1B and early-onset autosomal dominant Alzheimer disease: Dysregulated release of IL-1β is directly associated with the development and pathogenesis of various inflammation-mediated diseases, including arthritis, Alzheimer′s disease, allergies, and sepsis [9,35,36].